Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Fast-aging placentas may explain preeclampsia risks (opens in a new tab)

medicalxpress.com · 2026-10-26

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. 2 other points were not covered by the paper.

  • 4 supported
  • 1 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Four of seven check out. Two claims the study doesn't address.

  • 4 supported
  • 1 overstated
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedNew research led by Flinders University, in collaboration with the Robinson Research Institute at Adelaide University, has uncovered clues about why preeclampsia occurs, finding that a placenta may age prematurely.View evidenceHide evidence

Why this verdict

The paper profile supports accelerated molecular aging in late-onset preeclampsia placentae and mechanistic clues involving oxidative stress and TERRA loss. However, the claim/headline broadens this to 'why preeclampsia occurs' rather than specifically late-onset preeclampsia and implies etiologic explanation beyond what abstract-level evidence establishes. The 'may age prematurely' part is supported, but the headline framing outruns the narrower LOPE evidence.

1

Study evidence

LOPE placentae show accelerated molecular aging in primary tissue, manifested as telomere attrition, increased DNA damage, and trophoblast senescence, together with an angiogenic imbalance.

“Using primary placental tissue...”
2

Study evidence

Oxidative stress causes telomere shortening in primary placental tissue and trophoblast organoids.

“Using primary placental tissue and trophoblast organoids, we demonstrate oxidative stress as a driver of telomere shortening and angiogenic imbalance.”
Claim 2 of 7Not coveredThe work is published in the Proceedings of the National Academy of Sciences.View evidenceHide evidence

Why this verdict

The supplied paper profile is abstract-level scientific content and does not include verifiable publication-venue metadata confirming Proceedings of the National Academy of Sciences.

Claim 3 of 7Not coveredThe researchers say the findings could eventually help with prevention, earlier identification of at-risk pregnancies, and improved care, but further research is needed before new therapies can be used during pregnancy.View evidenceHide evidence

Why this verdict

The abstract-level profile supports mechanistic findings that could plausibly motivate future work, and it notes modifiable mechanisms. But it does not verify the specific translational claims about prevention, earlier identification of at-risk pregnancies, or improved care. The caveat that further research is needed before therapies in pregnancy is directionally appropriate, but the specific future applications are not established from the supplied abstract-depth profile.

1

Study evidence

Oxidative stress causes telomere shortening in primary placental tissue and trophoblast organoids.

“Using primary placental tissue and trophoblast organoids, we demonstrate oxidative stress as a driver of telomere shortening and angiogenic imbalance.”
2

Study evidence

Antioxidant treatment (superoxide dismutase) preserved telomere length in trophoblast organoids.

“Antioxidant treatment (superoxide dismutase) preserved telomere length, reduced DNA damage, and restored angiogenic balance...”
Claim 4 of 7SupportedResearchers examined placental tissue from healthy pregnancies and pregnancies affected by late-onset preeclampsia, and also used laboratory-grown mini-placentas called trophoblast organoids.View evidenceHide evidence

Why this verdict

The profile describes primary placental tissue comparisons between LOPE and controls and the use of trophoblast organoids as an experimental model. The exact characterization of controls as 'healthy pregnancies' is not detailed at abstract depth, but the main methods claim is supported.

1

Study evidence

LOPE placentae show accelerated molecular aging in primary tissue, manifested as telomere attrition, increased DNA damage, and trophoblast senescence, together with an angiogenic imbalance.

“Using primary placental tissue...”
2

Study evidence

Trophoblast organoids recapitulated aging-related readouts and responded to mechanistic perturbations described for LOPE (oxidative stress induced telomere attrition and angiogenic imbalance; antioxidant treatment preserved telomere length and reduced DNA damage), supporting their use as a tractable model of placental aging.

“...establish trophoblast organoids as a tractable model of placental aging...”
Claim 5 of 7SupportedThe team found that placentas affected by preeclampsia showed signs of accelerated aging, including increased DNA damage, shortened telomeres, and a buildup of aged cells.View evidenceHide evidence

Why this verdict

The profile directly states that LOPE placentae show accelerated molecular aging marked by telomere attrition, DNA damage, and trophoblast senescence, matching the story's shortened telomeres, increased DNA damage, and buildup of aged/senescent cells.

1

Study evidence

LOPE placentae show accelerated molecular aging in primary tissue, manifested as telomere attrition, increased DNA damage, and trophoblast senescence, together with an angiogenic imbalance.

“Using primary placental tissue...”
Claim 6 of 7SupportedResearchers identified oxidative stress as a major contributor to these changes, and say reducing oxidative stress in laboratory models lessened several markers of placental aging.View evidenceHide evidence

Why this verdict

The abstract-level profile explicitly describes oxidative stress as a driver of telomere shortening and angiogenic imbalance in placental/trophoblast models, and reports that antioxidant superoxide dismutase treatment preserved telomere length, reduced DNA damage, and restored angiogenic balance. The causal language is supported for the model experiments, though not for proven clinical intervention in pregnancy.

1

Study evidence

Oxidative stress causes telomere shortening in primary placental tissue and trophoblast organoids.

“Using primary placental tissue and trophoblast organoids, we demonstrate oxidative stress as a driver of telomere shortening and angiogenic imbalance.”
2

Study evidence

Antioxidant treatment (superoxide dismutase) preserved telomere length in trophoblast organoids.

“Antioxidant treatment (superoxide dismutase) preserved telomere length, reduced DNA damage, and restored angiogenic balance...”
Claim 7 of 7SupportedThe study also reported lower levels of telomeric repeat-containing RNAs (TERRAs) in preeclamptic placentas, and reduced TERRA levels in laboratory models made signs of cellular aging more pronounced.View evidenceHide evidence

Why this verdict

The profile reports reduced TERRA expression in LOPE placentae and antisense-mediated TERRA depletion in trophoblast organoids exacerbating telomere erosion and senescence, matching the story's claim that lower TERRA levels were observed and experimental reduction worsened cellular aging signs.

1

Study evidence

Abstract-level claim: TERRAs are reduced in LOPE placentae compared with controls (identified as a molecular hallmark of LOPE).

“We identify reduced expression of telomeric repeat-containing RNAs (TERRAs) as a molecular hallmark of LOPE...”
2

Study evidence

Antisense oligonucleotide-mediated depletion of TERRAs in trophoblast organoids exacerbates telomere erosion and increases trophoblast senescence.

“...show that antisense oligonucleotide-mediated TERRA depletion exacerbates telomere erosion and senescence.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Angiogenic imbalance is part of the LOPE placental aging phenotype and is affected by oxidative stress and antioxidant treatment.

    The story focuses on aging markers, oxidative stress, and TERRA but does not mention angiogenic imbalance, despite it being a repeated material endpoint in the paper profile.

    From Case-control primary placental tissue comparison; ex vivo human tissue and trophoblast organoid perturbation experiments

  • Inflammation was tested and did not alter the placental aging trajectory in the reported model context.

    The story does not mention the negative inflammation finding, which is a material contrast in the paper profile's mechanistic interpretation.

    From in vitro trophoblast organoid perturbation (with parallel primary placental tissue assays)

  • Generalizability from trophoblast organoid and ex vivo model findings to in vivo human pregnancy and clinical therapy is not established at abstract depth.

    The story caveat notes that further research is needed before therapies can be used during pregnancy, but it does not explicitly convey the model-to-human generalizability limitation for mechanistic organoid findings.

    From in vitro trophoblast organoid perturbation (with parallel primary placental tissue assays); Antioxidant rescue experimen

6 things the story did carry across
  • Late-onset preeclampsia placentae show accelerated molecular aging, including telomere attrition, DNA damage, and trophoblast senescence, based on primary placental tissue comparisons with controls.
  • The paper is specifically about late-onset preeclampsia rather than all forms of preeclampsia.
  • Oxidative stress is presented as a causal driver of telomere shortening/aging phenotypes and angiogenic imbalance in placental/trophoblast model systems.
  • Antioxidant treatment with superoxide dismutase mitigated aging-related phenotypes and restored angiogenic balance in model systems.
  • Reduced TERRA expression is reported as a hallmark of LOPE placentae, and experimental TERRA depletion worsens telomere erosion and senescence in trophoblast organoids.
  • Trophoblast organoids are used and positioned as a tractable experimental model for studying placental aging mechanisms.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

6

Evidence read

study summary

Lead result

ex vivo human

1Lead resultex vivo humanLate-onset preeclampsia (LOPE) placentae show accelerated molecular aging (telomere attrition, DNA damage, trophoblast senescence) with associated angiogenic imbalance.Case-control primary placental tissue comparison; ex vivo human tissue and trophoblast organoid perturbation experimentsExpand

In plain English

In primary placental tissue from late-onset preeclampsia (LOPE) cases versus non-LOPE controls, LOPE placentae display evidence of accelerated molecular aging — specifically telomere attrition, increased DNA damage, and trophoblast senescence — accompanied by an angiogenic imbalance. Mechanistic experiments in trophoblast organoids implicate oxidative stress as a driver of telomere shortening and angiogenic dysregulation (antioxidant superoxide dismutase preserved telomere length, reduced DNA damage, and restored angiogenic balance). LOPE placentae also show reduced expression of telomeric repeat-containing RNAs (TERRAs); experimental TERRA depletion by antisense oligonucleotides exacerbated telomere erosion and senescence. Inflammation did not shift the observed placental aging trajectories. The study positions trophoblast organoids as a model for placental aging and suggests oxidative stress and TERRA loss as modifiable mechanisms underlying LOPE-associated placental decline.

Key findings

  • LOPE placentae show accelerated molecular aging in primary tissue, manifested as telomere attrition, increased DNA damage, and trophoblast senescence, together with an angiogenic imbalance.
  • Oxidative stress is implicated as a driver of telomere shortening and angiogenic imbalance; antioxidant (superoxide dismutase) treatment preserved telomere length, reduced DNA damage, and restored angiogenic balance in experimental models.
“Using primary placental tissue...”
What this piece can’t prove

3 further details could not be confirmed from the summary.

2in vitroOxidative stress is a causal driver of telomere shortening/aging and angiogenic imbalance in placental/trophoblast models; inflammation is not a driver of the aging trajectory.in vitro trophoblast organoid perturbation (with parallel primary placental tissue assays)Expand

In plain English

In primary placental tissue and in vitro trophoblast organoids, oxidative stress manipulation produced accelerated molecular aging phenotypes (telomere shortening, DNA damage, trophoblast senescence) and disrupted angiogenic balance; inflammatory stimulation did not alter the observed placental aging trajectory. Antioxidant (superoxide dismutase) treatment mitigated telomere loss, DNA damage, and angiogenic imbalance in these model systems.

Key findings

  • Oxidative stress causes telomere shortening in primary placental tissue and trophoblast organoids.
  • Oxidative stress increases DNA damage and induces trophoblast senescence in organoid/tissue models.
“Using primary placental tissue and trophoblast organoids, we demonstrate oxidative stress as a driver of telomere shortening and angiogenic imbalance.”
What this piece can’t prove
  • Null effect of inflammation is reported without methodological detail; absence of effect may reflect specific stimuli/doses or sensitivity limits of the assays used.

2 further details could not be confirmed from the summary.

3in vitroAntioxidant treatment (superoxide dismutase) mitigates placental/trophoblast aging phenotypes and restores angiogenic balance, highlighting a modifiable mechanism.Antioxidant rescue experiment (SOD) in trophoblast organoidsExpand

In plain English

In trophoblast organoids, the authors report that antioxidant treatment with superoxide dismutase (SOD) preserved telomere length, reduced DNA damage, and restored angiogenic balance, consistent with oxidative stress acting as a modifiable driver of placental/trophoblast aging in the late-onset preeclampsia model.

Key findings

  • Antioxidant treatment (superoxide dismutase) preserved telomere length in trophoblast organoids.
  • Antioxidant treatment (superoxide dismutase) reduced DNA damage markers in trophoblast organoids.
“Antioxidant treatment (superoxide dismutase) preserved telomere length, reduced DNA damage, and restored angiogenic balance...”
What this piece can’t prove
  • The abstract does not specify controls, the exact assays used, or whether rescue effects fully reversed all aging phenotypes.

2 further details could not be confirmed from the summary.

4ex vivo humanReduced expression of telomeric repeat-containing RNAs (TERRAs) is a hallmark of LOPE, and experimental TERRA depletion worsens telomere erosion and senescence.Ex vivo human placental tissue comparative measurement (LOPE vs control)Expand

In plain English

The abstract reports that telomeric repeat-containing RNAs (TERRAs) are reduced in placentae from late-onset preeclampsia (LOPE) compared with controls, identifying reduced TERRA expression as a molecular hallmark of LOPE.

Key findings

  • Abstract-level claim: TERRAs are reduced in LOPE placentae compared with controls (identified as a molecular hallmark of LOPE).
“We identify reduced expression of telomeric repeat-containing RNAs (TERRAs) as a molecular hallmark of LOPE...”
What this piece can’t prove

3 further details could not be confirmed from the summary.

5in vitroReduced expression of telomeric repeat-containing RNAs (TERRAs) is a hallmark of LOPE, and experimental TERRA depletion worsens telomere erosion and senescence.In vitro ASO-mediated TERRA knockdown in trophoblast organoidsExpand

In plain English

In trophoblast organoids, antisense oligonucleotide (ASO)-mediated depletion of telomeric repeat-containing RNAs (TERRAs) worsens telomere shortening and increases cellular senescence, supporting a causal role for TERRA loss in driving telomere erosion and senescence-related placental aging features.

Key findings

  • Antisense oligonucleotide-mediated depletion of TERRAs in trophoblast organoids exacerbates telomere erosion and increases trophoblast senescence.
“...show that antisense oligonucleotide-mediated TERRA depletion exacerbates telomere erosion and senescence.”
What this piece can’t prove
  • Findings derive from an in vitro organoid perturbation and may not fully recapitulate in vivo placental biology or clinical LOPE.

2 further details could not be confirmed from the summary.

6in vitroTrophoblast organoids are established/validated as a tractable experimental model for studying placental aging mechanisms relevant to LOPE.in vitro trophoblast organoid derivation/cultureExpand

In plain English

The paper reports that trophoblast organoids were used alongside primary placental tissue to model placental aging and to interrogate mechanisms (oxidative stress driving telomere shortening, DNA damage, trophoblast senescence, and angiogenic imbalance). The authors state that trophoblast organoids function as a tractable experimental model for studying placental aging and for testing interventions (antioxidant treatment preserved telomere length and restored angiogenic balance in the organoid system).

Key findings

  • Trophoblast organoids recapitulated aging-related readouts and responded to mechanistic perturbations described for LOPE (oxidative stress induced telomere attrition and angiogenic imbalance; antioxidant treatment preserved telomere length and reduced DNA damage), supporting their use as a tractable model of placental aging.
“...establish trophoblast organoids as a tractable model of placental aging...”
What this piece can’t prove
  • Unclear whether organoid establishment is presented as a distinct set of data or primarily as the platform for perturbation experiments.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 38 candidate papers

Candidate

FORMATION OF STRUCTURE AND PHASE COMPOSITION DURING ANNEALING OF A FE-AL COMPOSITIONAL COATING OBTAINED BY HIGH-SPEED METALLIZATION

Materials Science · 2026 · Crossref

Source (opens in a new tab)

And 32 more candidates considered.